NCT00802074View on ClinicalTrials.gov

An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects

NACompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Healthy

Interventions

DRUG

Raltegravir

400mg BID

DRUG

Fosamprenavir

1400mg BID, 700 mg BID or 1400 mg QD

DRUG

Ritonavir

100 mg BID or QD

Trial Locations (1)

08043

Garden State Infectious Disease Associates, PA, Voorhees Township

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Garden State Infectious Disease Associates, PA

OTHER